Retatrutide Pen Where to Buy: What You Need to Know Before Purchasing
Understanding Retatrutide and Its Current Status Retatrutide has attracted considerable attention as a potential next-generation weight-management treatment. Developed by Eli Lilly, it is an investigational once-weekly injection that activates GIP, GLP-1, and glucagon receptors. Clinical trials have produced promising results for weight loss and related metabolic conditions. However, as of September 2026, retatrutide has not